Mutations, Biomarkers, and Pathways: A Molecular Tour of Gastrointestinal Cancer
Tracking # 20-1354953
Free
Course overview
This presentation will provide an overview of key molecular biomarkers that play a crucial role in the diagnosis, prognosis, and treatment of colon, gastric, and esophageal cancers. It will explore the latest advancements in biomarker discovery, highlighting their clinical utility. Attendees will gain insights into the molecular pathways driving these cancers and the implications of biomarkers such as microsatellite instability, HER2, and PD-L1 in guiding treatment decisions and improving patient outcomes. After this presentation, participants will be able to: - Identify key molecular biomarkers associated with colon, gastric, and esophageal cancers and their clinical significance - Explain the role of molecular biomarkers in the prognosis and therapeutic management of gastrointestinal cancers - Discuss the latest advancements in biomarker-driven targeted therapies and personalized medicine approaches for colon, gastric and esophageal cancer - Illustrate the molecular pathways involved in the pathogenesis of colon, gastric, and esophageal cancers and their implications for biomarker development
Subject areas
This course counts toward the state boards and subject areas below.